ReviewInternational journal of molecular sciences2022

PD-1/PD-L1 Immuno-Mediated Therapy in NAFLD: Advantages and Obstacles in the Treatment of Advanced Disease.

Rosa Lombardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.